≡ Menu

Thermographic Imaging Systems for Breast Cancer Screening: FDA Safety Communication

A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Thermographic Imaging Systems for Breast Cancer Screening: FDA Safety Communication. According to the Food & Drug Administration FDA’s MedWatch:

Thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer.

For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Thermographic Imaging Systems for Breast Cancer Screening: FDA Safety Communication.

To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.

If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.

{ 0 comments… add one }

Leave a Comment